Table 2 COG category of differentially-expressed genes in NCTC 11168 in response to treatment with a sub-inhibitory dose of Ery
From: Adaptive mechanisms of Campylobacter jejunito erythromycin treatment
COG category | No. up-regulated (%)* | No. down-regulated (%)* | Total No. differentially expressed genes |
|---|---|---|---|
Amino acid transport and metabolism | 6 (4.76%) | 5 (3.97%) | 11 |
Carbohydrate transport and metabolism | 1 (2.94%) | 2 (5.88%) | 3 |
Cell motility | 2 (3.85%) | 0 (0.00%) | 2 |
Cell wall/membrane biogenesis | 0 (0.00%) | 3 (2.52%) | 3 |
Coenzyme transport and metabolism | 1 (1.45%) | 2 (2.90%) | 3 |
Defense mechanisms | 1 (4.35%) | 1 (4.35%) | 2 |
Function unknown | 4 (5.63%) | 3 (4.23%) | 7 |
General function prediction only | 2 (1.41%) | 2 (1.41%) | 4 |
Inorganic ion transport and metabolism | 3 (3.70%) | 2 (4.94%) | 5 |
Lipid transport and metabolism | 1 (2.86%) | 2 (5.71%) | 3 |
Poorly characterized | 15 (2.81%) | 17 (5.71%) | 32 |
Posttranslational modification, chaperones | 0 (0.00%) | 1 (1.54%) | 1 |
Replication, recombination and repair | 0 (0.00%) | 1 (1.67%) | 1 |
Signal transduction mechanisms | 1 (2.22%) | 2 (4.44%) | 3 |
Transcription | 2 (4.65%) | 2 (4.65%) | 4 |
Translation | 0 (0.00%) | 1 (1.00%) | 1 |
Total | 39 | 46 | 85 |